NCT00456417View on ClinicalTrials.gov

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Alzheimers Disease

Interventions

DRUG

123-I MNI-187 Injection and Imaging Procedures

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

Sponsors

Collaborators (1)

Molecular NeuroImaging

All Listed Sponsors

collaborator

Molecular NeuroImaging

OTHER

lead

Institute for Neurodegenerative Disorders

OTHER